[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"degenerative-spine-diseases\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:degenerative-spine-diseases":67},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,40],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":4},"100557970",false,"NCT06545032","Minimal Invasive Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar and Lumbosacral Spine Diseases","Minimal Invasive Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar and Lumbosacral Spine Diseases : Clinical and Surgical Outcome","Inclusion Criteria:\n\n* Degenerative spondylolisthesis.\n* Degenerative unilateral disc herniations.\n* Recurrent disc herniation.\n\nExclusion Criteria:\n\n* Spondylolisthesis Grade III or IV.\n* Degenerative scoliosis .\n* Traumatic fracture spine.\n* Infections.\n* Neoplasms.\n* Debilitated patients .\n* Coagulation dysfunction.\n* Severe osteoporosis.",true,"ALL","18 Years","65 Years",{"count":20,"type":21},30,"ESTIMATED","INTERVENTIONAL",[24],"NA","The aim of this study is to evaluate clinical and surgical outcome of MI-TLIF for degenerative lumbar and lumbosacral spine diseases.",[27],"Degenerative Spine Diseases","NOT_YET_RECRUITING","2024-08-06",{"date":31,"type":32},"2024-08-09","ACTUAL",{"date":34,"type":21},"2024-09",{"date":36,"type":21},"2025-10",{"name":38,"class":39},"Sohag University","OTHER",{"id":41,"slug":4,"hasResults":10,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":4,"eligibilityCriteria":45,"healthyVolunteers":15,"sex":16,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":4,"studyType":22,"phases":50,"briefSummary":51,"conditions":52,"keywords":54,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":4},"100548965","NCT06427850","Effect of Topical Tranexamic Acid on Postoperative Drainage in Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF)","Effect of Topical Tranexamic Acid on Postoperative Drainage in Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF): A Randomized Controlled Trial","Inclusion Criteria:\n\n* Age 30-80 years old\n* Degenerative spine problems including spinal stenosis, disc degeneration, spondylolithesis that indicated for single level MI-TLIF\n\nExclusion Criteria:\n\n* Revision surgery\n* Patients who had high risk of complication from TXA\n* History of seizure, PE, DVT, thromboembolic episode\n* History of TXA allergy\n* Patients who had high risk for bleeding\n* U\u002FD : CKD stage more than IIIb (GFR\\\u003C 45 ml\u002Fmin\u002F1.73m2), hepatic disease, bleeding disorder\n* On anticoagulation drug or antiplatelet drug in 7 days before surgery\n* Abnormal coagulation profile (INR \\> 1.5) or CBC (platelet \\\u003C 100000)","30 Years","80 Years",{"count":49,"type":21},28,[24],"The randomized controlled study which compare the efficacy outcomes (reducing blood loss and drainage output in patients) in patients undergoing single-level minimally invasive transforaminal lumbar interbody fusion (MI-TLIF) and received topical tranexamic acid injection in the surgical site to those who received placebo injection.",[27,53],"Surgical Wound",[55,56,57],"Degenerative spine diseases","Surgical wound","Tranexamic acid (TXA)","2024-05-20",{"date":60,"type":32},"2024-05-24",{"date":62,"type":21},"2024-07-01",{"date":64,"type":21},"2026-12-01",{"name":66,"class":39},"Thanawan Longsuwan",""]